Jensen, MA
Carl Jensen, Waltham, MA US
Patent application number | Description | Published |
---|---|---|
20150071474 | TRANSMISSION LINE LOUDSPEAKER - An electro-acoustic driver including an acoustic waveguide includes an enclosure, an acoustic transmission line formed within the enclosure, and a plurality of acoustic transducers contained within the enclosure and disposed along a length of the acoustic transmission line. Each acoustic transducer is configured to emit acoustic energy directly into the acoustic transmission line at two separated locations along the length of the acoustic transmission line. | 03-12-2015 |
Christopher P. Jensen, Stoneham, MA US
Patent application number | Description | Published |
---|---|---|
20110209613 | APPARATUS AND METHOD FOR IN-SITU HIGH TEMPERATURE REGENERATION OF A ROTOR SORPTION CONCENTRATOR - A method and apparatus for regenerating the media of a rotary sorption concentrator system includes passing a 600° F. to 1000° F. regeneration fluid stream through a rotating media in a first isolated zone to regenerate the media and remove contaminants from the media that are not removed during a typical desorption cycle of a rotary sorption concentrator system. | 09-01-2011 |
David Richard Jensen, Waltham, MA US
Patent application number | Description | Published |
---|---|---|
20150038524 | CRYSTALLINE NALOXOL-PEG CONJUGATE - Naloxol-polyethylene glycol conjugates of the formula: are provided in oxalate or phosphate salt forms including crystalline forms. Methods of preparing the salt forms and pharmaceutical compositions comprising the salt forms are also provided. | 02-05-2015 |
Frances E. Jensen, Chestnut Hill, MA US
Patent application number | Description | Published |
---|---|---|
20130338424 | TRANSCRANIAL MAGNETIC STIMULATION (TMS) METHODS AND APPARATUS - Method and devices are provided for treating subjects with Transcranial Magnetic Stimulation (TMS). According to some approaches, the methods and devices are configured for the treatment of ongoing seizures. Other approaches relate to the use of TMS as an antiepileptogenic or for use in determining preferential placement of intracranial probes. | 12-19-2013 |
Frances E. Jensen, Boston, MA US
Patent application number | Description | Published |
---|---|---|
20100184650 | Treating post-seizure patients - Patients are subject to a post-seizure treatment regime to separately inhibitor consecutive targets of an epileptogenic cascade comprising neurotransmitter receptor signaling, kinase/phosphatase activity, protein translation, and apoptosis or inflammation. | 07-22-2010 |
20110237554 | Combination therapies: inhibitors of GABA transaminase and NKCC1 - Inhibitors of NKCC1, such as bumetanide, when coadministered with inhibitors of GABA transaminase, such as vigabatrin, attenuate both the retinal toxicity and the intramyelinic edema. | 09-29-2011 |
Jon M. Jensen, Sharon, MA US
Patent application number | Description | Published |
---|---|---|
20080307734 | Roof/wall structure - A roof/wall structure includes a substantially rigid substrate and a waterproof membrane adhesively joined to an outer surface of the substrate. The membrane includes a layer of thermoplastic or elastomeric waterproof material, a layer of cushion material bound to an inner surface of the layer of waterproof material, and a pressure sensitive adhesive bound to a side of the layer of cushion material remote from the layer of waterproof material and bound to the substrate. | 12-18-2008 |
20080309014 | Method for increasing puncture resistance of a waterproof membrane - A method for increasing puncture resistance of a thermoplastic or elastomeric membrane for use in water proofing of subterranean structural substrates, the method comprising bonding a layer of cushion material to the membrane, the cushion material comprising a cellular foam material and being adapted to conform around minor irregularities in a surface of the structural substrate. | 12-18-2008 |
20090113841 | Roof/wall structure - A roof/wall structure includes a substantially rigid substrate and a waterproof membrane adhesively joined to an outer surface of the substrate. The membrane includes a layer of thermoplastic or elastomeric waterproof material, a layer of cushion material bound to an inner surface of the layer of waterproof material, and a pressure sensitive adhesive bound to a side of the layer of cushion material remote from the layer of waterproof material and bound to the substrate. | 05-07-2009 |
Katharine Estelle Jensen, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20100084284 | Method and system for electrolytic fabrication of atomic clock cells - The present invention relates to a method and system for electrolytic fabrication of cells. A cell can be formed of a silicon layer (cathode) sandwiched between layers of glass. One or more holes are formed in the silicon layer. An alkali metal enriched glass material is placed in or associated with the one or more holes. Electrolysis is used to make the alkali metal ions in the alkali metal enriched glass material combine with electrons from the silicon cathode to form neutral alkali metal atoms in the one or more holes. | 04-08-2010 |
Klavs Jensen, Lexington, MA US
Patent application number | Description | Published |
---|---|---|
20080299539 | Parallel integrated bioreactor device and method - In one embodiment, the present invention introduces integrated fluid injection and mixing devices to enable pH control in a miniature parallel integrated bioreactor array system. In another embodiment, the environmental conditions of the growth chamber is enabled through fluidic injections in a miniature parallel cell culture system. In still another embodiment, the present invention utilizes gas switches to control oxygen concentration within a miniature parallel integrated bioreactor array. | 12-04-2008 |
Majken Jensen, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20110223158 | ASSOCIATION OF LEVELS OF HDL-CHOLESTEROL APOLIPOPROTEIN CIII WITH THE RISK OF CORONARY HEART DISEASE AND CARDIOVASCULAR EVENTS - Presented herein are methods of diagnosing, assessing, and treating an individual at increased risk if developing coronary heart disease or cardiovascular event, based on the individual's level of high density lipoprotein cholesterol apoCIII (HDL-C apoCIII). | 09-15-2011 |
Mallory Jensen, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20160029665 | APPARATUSES AND METHODS FOR ENCLOSING A FILLING IN A FOOD PRODUCT - A filling device comprises a modified vacuum-tilling head that introduces a viscous filling, such as a gravy, into a loaf matrix in a retortable can so that the tilling remains enclosed by the set loaf matrix after retorting. The tilling can remain as a viscous gravy or can set as a gel, depending on the formulation of the filling. Preferably the viscous filling is distributed horizontally into the loaf matrix, for example through horizontally-facing apertures, during a pause in the descent of the can away from the filling device. The flow of the filling can be controlled by synchronized pneumatic valves. | 02-04-2016 |
Ralph J. Jensen, Norwood, MA US
Patent application number | Description | Published |
---|---|---|
20150038464 | METHODS OF INCREASING LIGHT RESPONSIVENESS IN A SUBJECT WITH RETINAL DEGENERATION - Disclosed herein are methods of increasing retinal responsiveness to light in a subject, such as a subject with retinal degeneration. The disclosed methods include administering one or more compounds that decrease or inhibit γ-aminobutyric acid (GABA) signaling to a subject with retinal degeneration. In some embodiments, the methods include selecting a subject with retinal degeneration and administering a γ-aminobutyric acid C (GABA | 02-05-2015 |
Richard A. Jensen, Lexington, MA US
Patent application number | Description | Published |
---|---|---|
20080232800 | Method and apparatus for switching optical wavelengths - An example embodiment of the present invention is a non-blocking wavelength switching architecture that enables graceful scaling of a network wavelength switching node from small to large fiber counts using fixed size bidirectional 1×N Wavelength Selective Switches (WSS). The architecture uses an intermediate broadcast and select layer implemented using optical splitters and WSSs to eliminate wavelength blocking. | 09-25-2008 |
Richard Andrew Jensen, Lexington, MA US
Patent application number | Description | Published |
---|---|---|
20100027989 | Network Protection Switching Mechanisms and Methods of Network Protection - A network protection switching mechanism comprises a plurality of optical switches located at a plurality of nodes; a plurality of optical communication paths between said switches; switch based fault detectors located as part of at least two switches which generate detection results representative of the identification of a fault; switch based controllers located as part of said at least two switches; and internal switch-communication means between said fault detectors and said controllers which facilitate the transmission of detection results from said fault detectors to said controllers; wherein said controllers directly cause switching to an alternative optical communication path dependent upon the receipt of said detection results; whereby autonomous switch based protection without dependence on either inter-switch control communication or higher level network control communication is achieved. | 02-04-2010 |
Roderick V. Jensen, Pelham, MA US
Patent application number | Description | Published |
---|---|---|
20090104617 | Diagnostic and Prognostic Tests - The invention provides methods for diagnosing biological states or conditions based on ratios of gene expression data from tissue samples, such as cancer tissue samples. The invention also provides sets of genes that are expressed differentially in malignant pleural mesothelioma. These sets of genes can be used to discriminate between normal and malignant tissues, and between classes of malignant tissues. Accordingly, diagnostic assays for classification of tumors, prediction of tumor outcome, selecting and monitoring treatment regimens and monitoring tumor progression/regression also are provided. | 04-23-2009 |
20110059854 | DIAGNOSTIC AND PROGNOSTIC TESTS - The invention provides methods for diagnosing biological states or conditions based on ratios of gene expression data from tissue samples, such as cancer tissue samples. The invention also provides sets of genes that are expressed differentially in malignant pleural mesothelioma. These sets of genes can be used to discriminate between normal and malignant tissues, and between classes of malignant tissues. Accordingly, diagnostic assays for classification of tumors, prediction of tumor outcome, selecting and monitoring treatment regimens and monitoring tumor progression/regression also are provided. | 03-10-2011 |